Novartis AG (BCBA:NVS)

Elevation Oncology Revenue

Novartis AG had revenue of $14.84B USD in the quarter ending June 30, 2025, with 15.26% growth. This brings the company's revenue in the last twelve months to $55.19B, up 12.95% year-over-year. In the year 2024, Novartis AG had annual revenue of $51.72B with 10.85% growth.

• Revenue (ttm): $55.19B
• Revenue Growth: +12.95%
• P/S Ratio: 4.59
• Revenue / Employee: $727.25K
• Employees: 75,883
• Market Cap: 301.92T

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	51.72B	5.06B	10.85%
Dec 31, 2023	46.66B	3.20B	7.36%
Dec 31, 2022	43.46B	-513.00M	-1.17%
Dec 31, 2021	43.97B	-5.92B	-11.87%
Dec 31, 2020	49.90B	1.22B	2.51%